文献速递物质与行为成瘾

酒精使用障碍的MAO-B状态:[11C]SL25.1188 PET成像研究推定星形胶质增生

MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.
PubMed 文献 · Mol Psychiatry · 2025-11-25

本研究采用[11C]SL25.1188 PET成像比较健康对照(n=28)与酒精使用障碍(AUD)患者戒断3.5±3.7天(n=24)及24±7天(亚组n=8)的星形胶质细胞标志物MAO-B状态。AUD组平均结合无显著差异但变异性更大,且与AUD严重度、戒断和焦虑呈负相关(p<0.05),血浆GFAP和NF-L升高。

要点

  • AUD患者MAO-B PET结合均值与对照无显著差异,但个体变异性显著增大。
  • MAO-B结合与AUD严重度、戒断及焦虑呈负相关(p<0.05),提示低MAO-B与更重临床相关。
  • 每日吸烟与AUD组(-40%)及对照组(-33%)更低的MAO-B结合相关。

核心结论

  • AUD中MAO-B PET结合存在变异性,较低MAO-B与更大临床严重度相关,可能反映代偿性反应性星形胶质增生。

研究设计与样本

  • 采用[11C]SL25.1188 PET成像比较健康对照(n=28)与AUD患者戒断3.5±3.7天(n=24)及24±7天(亚组n=8)的MAO-B状态。

主要发现

  • AUD组与对照组平均[11C]SL25.1188结合在两个戒断时间点均无显著差异,但AUD组结合变异性更大。
  • MAO-B结合与AUD严重度、戒断和焦虑呈负相关(p<0.05)。
  • AUD患者血浆GFAP和NF-L升高。
  • 每日吸烟与AUD组(-40%)和对照组(-33%)更低的[11C]SL25.1188结合相关。

临床怎么用

  • MAO-B PET可能有助于识别AUD中星形胶质细胞反应异质性,但尚不能作为常规临床检测。
  • 吸烟对MAO-B结合的显著影响提示在解释胶质标志物影像时应考虑吸烟状态。

局限性

  • AUD戒断24天亚组样本量小(n=8),纵向证据有限。
  • 原文未报告效应量、置信区间及多重比较校正等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic alcohol exposure may trigger astrogliosis-a process involving hypertrophy and upregulation of astrocyte-specific markers following neuronal stress or injury-as suggested by trends in preclinical studies. However, in vivo evidence of astrogliosis in alcohol use disorder (AUD) is lacking. Here, we investigated the status of the astrocyte marker MAO-B -an enzyme predominantly expressed in astrocytes and upregulated during astrogliosis - using [11C]SL25.1188 positron emission tomography imaging in healthy controls (n = 28) and people with AUD after 3.5 ± 3.7 (n = 24) and 24 ± 7 days (in a subset: n = 8) of abstinence. Clinical symptoms of AUD were assessed, alongside peripheral markers of astrocyte activation and neuronal injury: glial fibrillary acidic protein (GFAP) and neurofilament light chain (NF-L), respectively. While mean [11C]SL25.1188 binding did not differ significantly between people with and without AUD at either abstinence time-point, binding was notably more variable in AUD and inversely correlated with AUD severity, withdrawal and anxiety (p < 0.05). Plasma GFAP and NF-L were elevated in people with AUD. Daily cigarette use was associated with lower [11C]SL25.1188 binding in people with AUD (-40%) and control participants (-33%). These findings reflect variability in MAO-B binding in AUD and support a potential link between lower MAO-B and greater clinical severity. The observed association between cigarette use and lower MAO-B binding replicates prior reports and extends this observation to AUD. The relationship between higher MAO-B binding and lower AUD severity may reflect compensatory reactive astrogliosis. Understanding whether MAO-B status reflects a beneficial or detrimental astrocytic response in AUD may be important for glial-targeted treatments.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Best LM, Truong J, McCluskey T, et al. MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis. Mol Psychiatry. 2025. PMID: 41291188. doi:10.1038/s41380-025-03355-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。